Autologous conditioned serum for degenerative diseases and prospects

References

• Alvarez, A. V., L. H. Boone, S. R. Pondugula, F. Caldwell, and A. A. Wooldridge. 2020. “Effects of Autologous Conditioned Serum, Autologous Protein Solution, and Triamcinolone on Inflammatory and Catabolic Gene Expression in Equine Cartilage and Synovial Explants Treated with IL-1β in co-Culture.” Frontiers in Veterinary Science 7: 323. doi:https://doi.org/10.3389/fvets.2020.00323.
   PubMedGoogle Scholar
• Álvarez-Camino, J. C., E. Vázquez-Delgado, and C. Gay-Escoda. 2013. “Use of Autologous Conditioned Serum (Orthokine) for the Treatment of the Degenerative Osteoarthritis of the Temporomandibular Joint. Review of the Literature.” Medicina Oral, Patologia Oral y Cirugia Bucal 18 (3): e433–e438. doi:https://doi.org/10.4317/medoral.18373.
   PubMed Web of Science ®Google Scholar
• Baltzer, A., C. Moser, S. Jansen, and R. J. Krauspe. 2009. “Autologous Conditioned Serum (Orthokine) is an Effective Treatment for Knee Osteoarthritis.” Osteoarthritis and Cartilage 17 (2): 152–160. doi:https://doi.org/10.1016/j.joca.2008.06.014.
   PubMed Web of Science ®Google Scholar
• Baltzer, A. W., M. S. Ostapczuk, D. Stosch, F. Seidel, and M. Granrath. 2013. “A New Treatment for Hip Osteoarthritis: clinical Evidence for the Efficacy of Autologous Conditioned Serum.” Orthopedic Reviews 5 (2): 13. doi:https://doi.org/10.4081/or.2013.e13.
   Google Scholar
• Barreto, A., and T. R. Braun. 2017. “A New Treatment for Knee Osteoarthritis: Clinical Evidence for the Efficacy of Arthrokinex™ Autologous Conditioned Serum.” Journal of Orthopaedics 14 (1): 4–9. doi:https://doi.org/10.1016/j.jor.2016.10.008.
   PubMedGoogle Scholar
• Baselga García-Escudero, J., and P. Miguel Hernández Trillos. 2015. “Treatment of Osteoarthritis of the Knee with a Combination of Autologous Conditioned Serum and Physiotherapy: A Two-Year Observational Study.” PLOS One 10 (12): e0145551. doi:https://doi.org/10.1371/journal.pone.0145551.
   PubMed Web of Science ®Google Scholar
• Becker, C., S. Heidersdorf, S. Drewlo, S. Z. de Rodriguez, J. Krämer, and R. E. J. S. Willburger. 2007. “Efficacy of Epidural Perineural Injections with Autologous Conditioned Serum for Lumbar Radicular Compression: An Investigator-Initiated, Prospective, Double-Blind, Reference-Controlled Study.” Spine 32 (17): 1803–1808. doi:https://doi.org/10.1097/BRS.0b013e3181076514.
   PubMed Web of Science ®Google Scholar
• Böni-Schnetzler, Marianne, Stéphanie P. Häuselmann, Elise Dalmas, Daniel T. Meier, Constanze Thienel, Shuyang Traub, Friederike Schulze, Laura Steiger, Erez Dror, Praxedis Martin, et al. 2018. “β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion.” Cell Reports 22 (7): 1774–1786. doi:https://doi.org/10.1016/j.celrep.2018.01.063.
   PubMedGoogle Scholar
• Brambilla, A., R. Caputo, R. Cimaz, and G. Simonini. 2016. “Canakinumab for Childhood Sight-Threatening Refractory Uveitis: A Case Series.” The Journal of Rheumatology 43 (7): 1445–1447. doi:https://doi.org/10.3899/jrheum.160064.
   PubMed Web of Science ®Google Scholar
• Cabrera, Susanne M., Xujing Wang, Yi-Guang Chen, Shuang Jia, Mary L. Kaldunski, Carla J. Greenbaum, Thomas Mandrup-Poulsen, Martin J. Hessner, Type 1 Diabetes TrialNet Canakinumab Study Group and AIDA Study Group. 2016. “Interleukin-1 Antagonism Moderates the Inflammatory State Associated with Type 1 Diabetes during Clinical Trials Conducted at Disease Onset.” European Journal of Immunology 46 (4): 1030–1046. doi:https://doi.org/10.1002/eji.201546005.
   PubMedGoogle Scholar
• Camargo Garbin, L., and M. J. Morris. 2021. “A Comparative Review of Autologous Conditioned Serum and Autologous Protein Solution in Osteoarthritis Treatment in Horses.” Frontiers in Veterinary Science 8: 82.
   Google Scholar
• Carlson, E. R., A. A. Stewart, K. L. Carlson, S. S. Durgam, and H. C. Pondenis. 2013. “Effects of Serum and Autologous Conditioned Serum on Equine Articular Chondrocytes Treated with Interleukin-1β.” American Journal of Veterinary Research 74 (5): 700–705. doi:https://doi.org/10.2460/ajvr.74.5.700.
   PubMedGoogle Scholar
• Cavalli, G., and C. A. Dinarello. 2018. “Anakinra Therapy for Non-Cancer Inflammatory Diseases.” Frontiers in Pharmacology 9: 1157. doi:https://doi.org/10.3389/fphar.2018.01157.
   PubMed Web of Science ®Google Scholar
• Chevalier, X., P. Goupille, A. D. Beaulieu, F. X. Burch, W. G. Bensen, T. Conrozier, D. Loeuille, A. J. Kivitz, D. Silver, and B. E. Appleton. 2009. “Intraarticular Injection of Anakinra in Osteoarthritis of the Knee: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study.” Arthritis and Rheumatism 61 (3): 344–352. doi:https://doi.org/10.1002/art.24096.
   PubMed Web of Science ®Google Scholar
• Crnogaca, K., G. Bicanic, and D. J. Delimar. 2016. “Elevated CRP Level Could Herald Less Efficient Autologous Conditioned Serum (ACS) Treatment.” Medical Hypotheses 86: 135–137. doi:https://doi.org/10.1016/j.mehy.2015.11.001.
   PubMedGoogle Scholar
• Damjanov, N., B. Barac, J. Colic, V. Stevanovic, A. Zekovic, and G. J. Tulic. 2018. “The Efficacy and Safety of Autologous Conditioned Serum (ACS) Injections Compared with Betamethasone and Placebo Injections in the Treatment of Chronic Shoulder Joint Pain Due to Supraspinatus Tendinopathy: A Prospective, Randomized, Double-Blind, Controlled Study.” Medical Ultrasonography 20 (3): 335–341. doi:https://doi.org/10.11152/mu-1495.
   PubMedGoogle Scholar
• Darabos, N., M. Haspl, C. Moser, A. Darabos, D. Bartolek, and D. Groenemeyer. 2011. “Intraarticular Application of Autologous Conditioned Serum (ACS) Reduces Bone Tunnel Widening after ACL Reconstructive Surgery in a Randomized Controlled Trial Knee Surgery.” Knee Surgery, Sports Traumatology, Arthroscopy 19 (S1): 36–46. doi:https://doi.org/10.1007/s00167-011-1458-4.
   Google Scholar
• de Girolamo, L., E. Kon, G. Filardo, A. G. Marmotti, F. Soler, G. M. Peretti, F. Vannini, H. Madry, and S. Chubinskaya. 2016. “Regenerative Approaches for the Treatment of Early OA.” Knee Surgery, Sports Traumatology, Arthroscopy 24 (6): 1826–1835. doi:https://doi.org/10.1007/s00167-016-4125-y.
   PubMedGoogle Scholar
• de Witte, S. F., A. M. Merino, M. Franquesa, T. Strini, J. A. A. van Zoggel, S. S. Korevaar, F. Luk, M. Gargesha, L. O'Flynn, D. Roy, et al. 2017. “Cytokine Treatment Optimises the Immunotherapeutic Effects of Umbilical Cord-Derived MSC for Treatment of Inflammatory Liver Disease.” Stem Cell Research & Therapy 8: 1–12.
   PubMedGoogle Scholar
• Deshpande, Bhushan R., Jeffrey N. Katz, Daniel H. Solomon, Edward H. Yelin, David J. Hunter, Stephen P. Messier, Lisa G. Suter, and E. Losina. 2016. “Number of Persons with Symptomatic Knee Osteoarthritis in the US: impact of Race and Ethnicity, Age, Sex, and Obesity.” Arthritis Care & Research 68 (12): 1743–1750. doi:https://doi.org/10.1002/acr.22897.
   PubMed Web of Science ®Google Scholar
• Dolati, S., S. K. Shakouri, N. Dolatkhah, M. Yousefi, F. Jadidi‐Niaragh, and S. Sanaie. 2021. “The Role of Exosomal Non‐Coding RNAs in Aging‐Related Diseases.” BioFactors 47 (3): 292–310. doi:https://doi.org/10.1002/biof.1715.
   PubMedGoogle Scholar
• Dolati, S., M. Yousefi, A. Pishgahi, S. Nourbakhsh, B. Pourabbas, and S. K. Shakouri. 2020. “Prospects for the Application of Growth Factors in Wound Healing.” Growth Factors 38 (1): 25–34. doi:https://doi.org/10.1080/08977194.2020.1820499.
   PubMed Web of Science ®Google Scholar
• Donath, M. Y., C. A. Dinarello, and T. Mandrup-Poulsen. 2019. “Targeting Innate Immune Mediators in Type 1 and Type 2 Diabetes.” Nature Reviews Immunology 19 (12): 734–746. doi:https://doi.org/10.1038/s41577-019-0213-9.
   PubMed Web of Science ®Google Scholar
• Evans, C. H., X. Chevalier, P. J. P. M. Wehling, and R. Clinics. 2016. “Autologous Conditioned Serum.” Physical Medicine and Rehabilitation Clinics of North America 27 (4): 893–908. doi:https://doi.org/10.1016/j.pmr.2016.06.003.
   PubMed Web of Science ®Google Scholar
• Evans, C. H., V. B. Kraus, and L. A. Setton. 2014. “Progress in Intra-Articular Therapy.” Nature Reviews Rheumatology 10 (1): 11–22. doi:https://doi.org/10.1038/nrrheum.2013.159.
   PubMed Web of Science ®Google Scholar
• Ferris, R. A., D. D. Frisbie, and P. M. McCue. 2014. “Use of Mesenchymal Stem Cells or Autologous Conditioned Serum to Modulate the Inflammatory Response to Spermatozoa in Mares.” Theriogenology 82 (1): 36–42. doi:https://doi.org/10.1016/j.theriogenology.2014.02.015.
   PubMedGoogle Scholar
• Fjordbakk, C., G. Johansen, A. Løvås, K. Oppegård, and A. Storset. 2015. “Surgical Stress Influences Cytokine Content in Autologous Conditioned Serum.” Equine Veterinary Journal 47 (2): 212–217. doi:https://doi.org/10.1111/evj.12277.
   PubMedGoogle Scholar
• Fotouhi, A., A. Maleki, S. Dolati, A. Aghebati-Maleki, and L. J. B. Aghebati-Maleki. 2018. “Platelet Rich Plasma, Stromal Vascular Fraction and Autologous Conditioned Serum in Treatment of Knee Osteoarthritis.” Biomedicine & Pharmacotherapy 104: 652–660. doi:https://doi.org/10.1016/j.biopha.2018.05.019.
   PubMedGoogle Scholar
• Frisbie, D. D. J. 2015. “Autologous-Conditioned Serum: evidence for Use in the Knee.” The Journal of Knee Surgery 28 (1): 63–066.
   PubMedGoogle Scholar
• Frizziero, A., E. Giannotti, F. Oliva, S. Masiero, and N. Maffulli. 2013. “Autologous Conditioned Serum for the Treatment of Osteoarthritis and Other Possible Applications in Musculoskeletal Disorders.” British Medical Bulletin 105: 169–184.
   PubMed Web of Science ®Google Scholar
• Geburek, F., M. Lietzau, A. Beineke, K. Rohn, and P. M. Stadler. 2015. “Effect of a Single Injection of Autologous Conditioned Serum (ACS) on Tendon Healing in Equine Naturally Occurring Tendinopathies.” Stem Cell Research & Therapy 6: 1–14.
   PubMedGoogle Scholar
• Genç, E., O. Beytemur, S. Yuksel, Y. Eren, A. Çağlar, B. O. Küçükyıldırım, and M. A. Güleç. 2018. “Investigation of the Biomechanical and Histopathological Effects of Autologous Conditioned Serum on Healing of Achilles Tendon.” Acta Orthopaedica et Traumatologica Turcica 52 (3): 226–231. doi:https://doi.org/10.1016/j.aott.2018.01.005.
   PubMedGoogle Scholar
• Genç, E., S. Yüksel, A. Çağlar, O. Beytemur, and M. A. Güleç. 2020. “Comparison on Effects of Platelet-Rich Plasma versus Autologous Conditioned Serum on Achilles Tendon Healing in a Rat Model.” Acta Orthopaedica et Traumatologica Turcica 54: 438.
   PubMedGoogle Scholar
• Goni, Vijay G., Sampat Singh Jhala, Nirmal Raj Gopinathan, Prateek Behera, Y. K. Batra, R. H. H. Arjun, Uday Guled, Harsha Vardhan. 2015. “Efficacy of Epidural Perineural Injection of Autologous Conditioned Serum in Unilateral Cervical Radiculopathy: A Pilot Study.” Spine 40 (16): E915–E921. doi:https://doi.org/10.1097/BRS.0000000000000924.
   PubMedGoogle Scholar
• Hashemi, M., M. Taheri, H. Adlkhoo, P. Dadkhah, and M. R. Abbasian. 2019. “Comparison of the Effect of Intra-Articular Injection of Autologous (Orthokine) Interleukin-1 Receptor Antagonist (IL-1Ra) and Hyaluronic Acid in Pain Control of Knee Osteoarthritis.” Novelty in Biomedicine 7: 210–217.
   Google Scholar
• Heisterbach, P. E., A. Todorov, R. Flückiger, C. H. Evans, and M. J. K. S. Majewski. 2012. “Effect of BMP-12, TGF-β1 and Autologous Conditioned Serum on Growth Factor Expression in Achilles Tendon Healing.” Knee Surgery, Sports Traumatology, Arthroscopy 20 (10): 1907–1914. doi:https://doi.org/10.1007/s00167-011-1772-x.
   PubMedGoogle Scholar
• Hermann, W., S. Lambova, and U. Muller-Ladner. 2018. “Current Treatment Options for Osteoarthritis.” Current Rheumatology Reviews 14 (2): 108–116. doi:https://doi.org/10.2174/1573397113666170829155149.
   PubMed Web of Science ®Google Scholar
• Hraha, T., K. Doremus, C. McIlwraith, and D. Frisbie. 2011. “Autologous Conditioned Serum: The Comparative Cytokine Profiles of Two Commercial Methods (IRAP and IRAP II) Using Equine Blood.” Equine Veterinary Journal 43 (5): 516–521. doi:https://doi.org/10.1111/j.2042-3306.2010.00321.x.
   PubMedGoogle Scholar
• Kaneko, N., M. Kurata, T. Yamamoto, S. Morikawa, and J. J. Masumoto. 2019. “The Role of Interleukin-1 in General Pathology.” Inflammation and Regeneration 39: 1–16.
   PubMedGoogle Scholar
• Khurana, A., A. Goyal, P. Kirubakaran, G. Akhand, R. Gupta, and N. Goel. 2020. “Efficacy of Autologous Conditioned Serum (ACS), Platelet-Rich Plasma (PRP), Hyaluronic Acid (HA) and Steroid for Early Osteoarthritis Knee: A Comparative Analysis.” Indian Journal of Orthopaedics 55: 217–227.
   PubMedGoogle Scholar
• Lasarzik, J., Angelika Bondzio, Matthias Rettig, Roberto Estrada, Christoph Klaus, Anna Ehrle, Ralf Einspanier, and Christoph Johannes Lischer. 2018. “Evaluation of Two Protocols Using Autologous Conditioned Serum for Intra-Articular Therapy of Equine Osteoarthritis—a Pilot Study Monitoring Cytokines and Cartilage-Specific Biomarkers.” Journal of Equine Veterinary Science 60: 35–42.e32.
   Google Scholar
• Lin, Jin, Jing Li, Bo Huang, Jing Liu, Xin Chen, Xi-Min Chen, Yan-Mei Xu, Lin-Feng Huang, and Xiao-Zhong Wang. 2015. “Exosomes: Novel Biomarkers for Clinical Diagnosis.” The Scientific World Journal 2015: 1–8. doi:https://doi.org/10.1155/2015/657086.
   Google Scholar
• Lopalco, G., S. Schiraldi, V. Venerito, S. Guerriero, and F. J. Iannone. 2020. “Effectiveness and Safety Profile of Anakinra in a HLA-B27 Positive Patient with Multiple Sclerosis-Associated Uveitis.” Multiple Sclerosis and Related Disorders 42: 102152. doi:https://doi.org/10.1016/j.msard.2020.102152.
   PubMed Web of Science ®Google Scholar
• Majewski, M., P. E. Ochsner, F. Liu, R. Flückiger, and C. H. Evans. 2009. “Accelerated Healing of the Rat Achilles Tendon in Response to Autologous Conditioned Serum.” The American Journal of Sports Medicine 37 (11): 2117–2125. doi:https://doi.org/10.1177/0363546509348047.
   PubMedGoogle Scholar
• Maquirriain, J. 2011. “Achilles Tendon Rupture: Avoiding Tendon Lengthening during Surgical Repair and Rehabilitation.” The Yale Journal of Biology and Medicine 84 (3): 289–300.
   PubMedGoogle Scholar
• Marques-Smith, P., Anne S. Kallerud, Grethe M. Johansen, Preben Boysen, Anna M. Jacobsen, Karoline M. Reitan, Mia M. Henriksen, Maria Löfgren, and Cathrine T. Fjordbakk. 2020. “Is Clinical Effect of Autologous Conditioned Serum in Spontaneously Occurring Equine Articular Lameness Related to ACS Cytokine Profile?” BMC Veterinary Research 16: 1–9.
   PubMedGoogle Scholar
• Mathiessen, A., and P. G. Conaghan. 2017. “Synovitis in Osteoarthritis: Current Understanding with Therapeutic Implications.” Arthritis Research & Therapy 19: 1–9.
   PubMedGoogle Scholar
• Mazzocca, Augustus D., Mary Beth R. McCarthy, David M. Chowaniec, Mark P. Cote, Anthony A. Romeo, James P. Bradley, Robert A. Arciero, and K. Beitzel. 2012. “Platelet-Rich Plasma Differs According to Preparation Method and Human Variability.” The Journal of Bone and Joint Surgery. American Volume 94 (4): 308–316. doi:https://doi.org/10.2106/JBJS.K.00430.
   PubMed Web of Science ®Google Scholar
• Mehta, S., S. Akhtar, R. M. Porter, P. Önnerfjord, and A. G. Bajpayee. 2019. “Interleukin-1 Receptor Antagonist (IL-1Ra) is More Effective in Suppressing Cytokine-Induced Catabolism in Cartilage-Synovium co-Culture than in Cartilage Monoculture.” Arthritis Research & Therapy 21: 1–15.
   PubMedGoogle Scholar
• Mills, K. H., L. S. Dungan, S. A. Jones, and J. Harris. 2013. “The Role of Inflammasome-Derived IL-1 in Driving IL-17 Responses.” Journal of Leukocyte Biology 93 (4): 489–497. doi:https://doi.org/10.1189/jlb.1012543.
   PubMed Web of Science ®Google Scholar
• Moran, Antoinette, Brian Bundy, Dorothy J. Becker, Linda A. DiMeglio, Stephen E. Gitelman, Robin Goland, Carla J. Greenbaum, Kevan C. Herold, Jennifer B. Marks, Philip Raskin, et al. 2013. “Interleukin-1 Antagonism in Type 1 Diabetes of Recent Onset: Two Multicentre, Randomised, Double-Blind, Placebo-Controlled Trials.” The Lancet 381 (9881): 1905–1915. doi:https://doi.org/10.1016/S0140-6736(13)60023-9.
   PubMed Web of Science ®Google Scholar
• Motaal, F. K. A.-E., A. M. Elganzoury, M. M. Fathalla, and O. Abdulkareem. 2014. “Low-Dose Intra-Articular Autologous Conditioned Serum in Treatment of Primary Knee Osteoarthritis.” Egyptian Rheumatology and Rehabilitation 41 (3): 98–102. doi:https://doi.org/10.4103/1110-161X.140523.
   Google Scholar
• Nixon, Alan J., Matthew W. Grol, Hayley M. Lang, Merry Z. C. Ruan, Adrianne Stone, Laila Begum, Yuqing Chen, Brian Dawson, Francis Gannon, Stanislav Plutizki, et al. 2018. “Disease-Modifying Osteoarthritis Treatment with Interleukin-1 Receptor Antagonist Gene Therapy in Small and Large Animal Models.” Arthritis & Rheumatology 70 (11): 1757–1768. doi:https://doi.org/10.1002/art.40668.
   PubMed Web of Science ®Google Scholar
• Norris, P. C., S. Libreros, N. Chiang, and C. N. Serhan. 2017. “A Cluster of Immunoresolvents Links Coagulation to Innate Host Defense in Human Blood.” Science Signaling 10: eaan1471.
   PubMedGoogle Scholar
• Oh, Seung-Hun, Chunggab Choi, Jeong-Eun Noh, Nayeon Lee, Yong-Woo Jeong, Iksoo Jeon, Jeong-Min Shin, Ji-Hye Kim, Ho-Jin Kim, Ji-Min Lee, et al. 2018. “Interleukin-1 Receptor Antagonist-Mediated Neuroprotection by Umbilical Cord-Derived Mesenchymal Stromal Cells following Transplantation into a Rodent Stroke Model.” Experimental & Molecular Medicine 50 (4): 1–12. doi:https://doi.org/10.1038/s12276-018-0041-1.
   Google Scholar
• Pishgahi, Alireza, Rozita Abolhasan, Seyed Kazem Shakouri, Mohammad Sadegh Soltani-Zangbar, Shahla Dareshiri, Sepideh Ranjbar Kiyakalayeh, Amirghasem Khoeilar, Majid Zamani, Farhad Motavalli Khiavi, Behzad Pourabbas Kheiraddin, et al. 2020. “Effect of Dextrose Prolotherapy, Platelet Rich Plasma and Autologous Conditioned Serum on Knee Osteoarthritis: A Randomized Clinical Trial.” Iranian Journal of Allergy, Asthma and Immunology 19: 243–252. doi:https://doi.org/10.18502/ijaai.v19i3.3452.
   PubMedGoogle Scholar
• Pradillo, Jesus M., Katie N. Murray, Graham A. Coutts, Ana Moraga, Fernando Oroz-Gonjar, Herve Boutin, Maria A. Moro, Ignacio Lizasoain, Nancy J. Rothwell, and Stuart M. Allan. 2017. “Reparative Effects of Interleukin-1 Receptor Antagonist in Young and Aged/co-Morbid Rodents after Cerebral Ischemia.” Brain, Behavior, and Immunity 61: 117–126. doi:https://doi.org/10.1016/j.bbi.2016.11.013.
   PubMedGoogle Scholar
• Ravi Kumar, H., V. G. Goni, and Y. J. Batra. 2015. “Autologous Conditioned Serum as a Novel Alternative Option in the Treatment of Unilateral Lumbar Radiculopathy: A Prospective Study.” Asian Spine Journal 9 (6): 916. doi:https://doi.org/10.4184/asj.2015.9.6.916.
   PubMedGoogle Scholar
• Rey-Rico, A., J. Reinecke, P. Wehling, M. Cucchiarini, and H. J. Madry. 2015. “Effects of Exosomes upon the Metabolic Activities of Human Osteoarthritic Articular Cartilage In Situ.” Osteoarthritis and Cartilage 23: A399. doi:https://doi.org/10.1016/j.joca.2015.02.736.
   Google Scholar
• Rikhtegar, R., M. Yousefi, S. Dolati, H. D. Kasmaei, S. Charsouei, M. Nouri, and S. K. Shakouri. 2019. “Stem Cell-Based Cell Therapy for Neuroprotection in Stroke: A Review.” Journal of Cellular Biochemistry 120 (6): 8849–8862. doi:https://doi.org/10.1002/jcb.28207.
   PubMedGoogle Scholar
• Rutgers, M., D. B. Saris, W. J. Dhert, and L. B. Creemers. 2010. “Cytokine Profile of Autologous Conditioned Serum for Treatment of Osteoarthritis, In Vitro Effects on Cartilage Metabolism and Intra-Articular Levels after Injection.” Arthritis Research & Therapy 12: 1–11.
   Google Scholar
• Sarıkaya, B., N. Yumuşak, A. Yigin, S. Sipahioğlu, Ü. Yavuz, and M. A. J. J. D. Altay. 2017. “Comparison of the Effects of Human Recombinant Epidermal Growth Factor and Platelet-Rich Plasma on Healing of Rabbit Patellar Tendon.” Eklem Hastaliklari ve Cerrahisi [Joint Diseases & Related Surgery] 28 (2): 92–099.
   PubMedGoogle Scholar
• Shirokova, K., S. Noskov, and L. Shirokova. 2017. “Comparison of Clinical Efficacy of Platelet-Rich Plasma and Autologous Conditioned Serum Treatment in Patients with Osteoarthritis of the Knee.” Osteoarthritis and Cartilage 25: S438. doi:https://doi.org/10.1016/j.joca.2017.02.756.
   PubMedGoogle Scholar
• Shirokova, L., S. Noskov, V. Gorokhova, J. Reinecke, and K. Shirokova. 2020. “Intra-Articular Injections of a Whole Blood Clot Secretome, Autologous Conditioned Serum, Have Superior Clinical and Biochemical Efficacy over Platelet-Rich Plasma and Induce Rejuvenation-Associated Changes of Joint Metabolism.” Rejuvenation Research 23 (5): 401–410.
   PubMedGoogle Scholar
• Steel, C., R. Pannirselvam, and G. Anderson. 2013. “Risk of Septic Arthritis after Intra-Articular Medication: A Study of 16,624 Injections in Thoroughbred Racehorses.” Australian Veterinary Journal 91 (7): 268–273. doi:https://doi.org/10.1111/avj.12073.
   PubMedGoogle Scholar
• Strümper, R. 2017. “Intra-Articular Injections of Autologous Conditioned Serum to Treat Pain from Meniscal Lesions.” Sports Medicine International Open 1 (06): E200–E205. doi:https://doi.org/10.1055/s-0043-118625.
   PubMedGoogle Scholar
• Sulzbacher, I. J. W. M. W. 2013. “Osteoarthritis: Histology and Pathogenesis.” Wiener Medizinische Wochenschrift 163 (9–10): 212–219. doi:https://doi.org/10.1007/s10354-012-0168-y.
   PubMedGoogle Scholar
• Sun, Xiaoxiao, Haipeng Pang, Jiaqi Li, Shuoming Luo, Gan Huang, Xia Li, Zhiguo Xie, and Zhiguang Zhou. 2020. “The NLRP3 Inflammasome and Its Role in T1DM.” Frontiers in Immunology 11: 1595. doi:https://doi.org/10.3389/fimmu.2020.01595.
   PubMedGoogle Scholar
• Tassara, M., A. De Ponti, L. Barzizza, M. Zambelli, C. Parisi, R. Milani, and L. Santoleri. 2018. “Autologous Conditioned Serum (ACS) for Intra-Articular Treatment in Osteoarthritis: Retrospective Report of 28 Cases.” Transfusion and Apheresis Science 57 (4): 573–577. doi:https://doi.org/10.1016/j.transci.2018.07.021.
   PubMedGoogle Scholar
• Tatarniuk, D. 2015. Autologous Conditioned Serum and Subsequent Synovial Fluid Concentrations of Cytokines, Matrix Metalloproteinases, and Tissue Inhibitors of Metalloproteinases after Injection into Equine Osteoarthritic Distal Interphalangeal Joints. The University of Minnesota Digital Conservancy. ProQuest Dissertations Publishing; p. 89. https://hdl.handle.net/11299/174725.
   Google Scholar
• Tomlinson, F., J. Terschuur, and F. J. V. R. Henson. 2021. “Use of Autologous Products for the Treatment of Joint and Soft Tissue Disease in Horses: A Systematic Review.” Veterinary Record 188: e9.
   PubMedGoogle Scholar
• Tsalamandris, Sotirios, Alexios S. Antonopoulos, Evangelos Oikonomou, George-Aggelos Papamikroulis, Georgia Vogiatzi, Spyridon Papaioannou, Spyros Deftereos, and Dimitris Tousoulis. 2019. “The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives.” European Cardiology 14 (1): 50–59. doi:https://doi.org/10.15420/ecr.2018.33.1.
   PubMed Web of Science ®Google Scholar
• Vangsness, C. T. Jr., Farr, Jack I. Boyd, J. Dellaero, D. T. Mills, C. R. LeRoux-Williams. and M.   2014. “Adult Human Mesenchymal Stem Cells Delivered via Intra-Articular Injection to the Knee following Partial Medial Meniscectomy: A Randomized, Double-Blind, Controlled Study.” The Journal of Bone and Joint Surgery. American Volume 96 (2): 90–98. doi:https://doi.org/10.2106/JBJS.M.00058.
   PubMedGoogle Scholar
• Vitali, M., M. Ometti, A. Drossinos, P. Pironti, L. Santoleri, and V. Salini. 2020. “Autologous Conditioned Serum: Clinical and Functional Results Using a Novel Disease Modifying Agent for the Management of Knee Osteoarthritis.” Journal of Drug Assessment 9 (1): 43–51. doi:https://doi.org/10.1080/21556660.2020.1734009.
   PubMed Web of Science ®Google Scholar
• von Wehren, L., F. Blanke, A. Todorov, P. Heisterbach, J. Sailer, and M. J. K. S. Majewski. 2016. “The Effect of Subacromial Injections of Autologous Conditioned Plasma versus Cortisone for the Treatment of Symptomatic Partial Rotator Cuff Tears.” Knee Surgery, Sports Traumatology, Arthroscopy 24 (12): 3787–3792. doi:https://doi.org/10.1007/s00167-015-3651-3.
   PubMedGoogle Scholar
• Wehling, P., C. Evans, J. Wehling, and WJTaimd Maixner. 2017. “Effectiveness of Intra-Articular Therapies in Osteoarthritis: A Literature Review.” Therapeutic Advances in Musculoskeletal Disease 9 (8): 183–196. doi:https://doi.org/10.1177/1759720X17712695.
   PubMed Web of Science ®Google Scholar
• Wehling, P., C. Moser, D. Frisbie, C. W. McIlwraith, C. E. Kawcak, R. Krauspe, and J. A. J. B. Reinecke. 2007. “Autologous Conditioned Serum in the Treatment of Orthopedic Diseases: The Orthokine Therapy.” BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 21 (5): 323–332. doi:https://doi.org/10.2165/00063030-200721050-00004.
   PubMed Web of Science ®Google Scholar
• Weisshaar, M., J. Ghanam, S. Irsen, J. Reinecke, and P. Wehling. 2018. “Inflammatory Molecules Are Cell-to-Cell Transported by Exosomes in the anti-Inflammatory Human Autologous Conditioned Serum.” Journal of Extracellular Vesicles 7: 142–142.
   Google Scholar
• Wojdasiewicz, P., Ł. A. Poniatowski, and D. Szukiewicz. 2014. “The Role of Inflammatory and anti-Inflammatory Cytokines in the Pathogenesis of Osteoarthritis.” Mediators of Inflammation 2014: 1–19. doi:https://doi.org/10.1155/2014/561459.
   Web of Science ®Google Scholar
• Wright-Carpenter, T., P. Klein, P. Schäferhoff, H. Appell, L. Mir, and P. Wehling. 2004. “Treatment of Muscle Injuries by Local Administration of Autologous Conditioned Serum: A Pilot Study on Sportsmen with Muscle Strains.” International Journal of Sports Medicine 25 (8): 588–593. doi:https://doi.org/10.1055/s-2004-821304.
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó, María, Pia R.-M. Siljander, Zoraida Andreu, Apolonija Bedina Zavec, Francesc E. Borràs, Edit I. Buzas, Krisztina Buzas, Enriqueta Casal, Francesco Cappello, Joana Carvalho, et al. 2015. “Biological Properties of Extracellular Vesicles and Their Physiological Functions.” Journal of Extracellular Vesicles 4: 27066. doi:https://doi.org/10.3402/jev.v4.27066.
   PubMed Web of Science ®Google Scholar
• Yang, C., and P. D. Robbins. 2012. “Immunosuppressive Exosomes: A New Approach for Treating Arthritis.” International Journal of Rheumatology 2012: 573528. doi:https://doi.org/10.1155/2012/573528.
   PubMedGoogle Scholar
• Yang, K. G. Auw., N. J. H. Raijmakers, E. R. A. van Arkel, J. J. Caron, P. C. Rijk, W. J. Willems, J. A. C. Zijl, A. J. Verbout, W. J. A. Dhert, and D. B. F. Saris. 2008. “Autologous Interleukin-1 Receptor Antagonist Improves Function and Symptoms in Osteoarthritis When Compared to Placebo in a Prospective Randomized Controlled Trial.” Osteoarthritis and Cartilage 16 (4): 498–505. doi:https://doi.org/10.1016/j.joca.2007.07.008.
   PubMed Web of Science ®Google Scholar
• YükSel, S., O. AdAnır, M. Z. Gültekİn, A. ÇAğlAr, B. O. Küçükyıldırım, M. A. Güleç, and E. J. A. O. T. T. Alagöz. 2015. “Effect of Platelet-Rich Plasma for Treatment of Achilles Tendons in Free-Moving Rats after Surgical Incision and Treatment.” Acta Orthopaedica et Traumatologica Turcica 49 (5): 544–551. doi:https://doi.org/10.3944/AOTT.2015.15.0028.
   PubMedGoogle Scholar
• Zarringam, D., J. E. Bekkers, and D. B. Saris. 2018. “Long-Term Effect of Injection Treatment for Osteoarthritis in the Knee by Orthokin Autologous Conditioned Serum.” Cartilage 9 (2): 140–145. doi:https://doi.org/10.1177/1947603517743001.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., L. Li, W. Yang, Y. Cao, Y. Shi, X. Li, and Q. Zhang. 2017. “The Effects of Different Doses of IGF-1 on Cartilage and Subchondral Bone during the Repair of Full-Thickness Articular Cartilage Defects in Rabbits.” Osteoarthritis and Cartilage 25 (2): 309–320. doi:https://doi.org/10.1016/j.joca.2016.09.010.
   PubMedGoogle Scholar
• Zhou, Q., B. Li, J. Zhao, W. Pan, J. Xu, and S. J. I. V. C. Chen. 2016. “IGF-I Induces Adipose Derived Mesenchymal Cell Chondrogenic Differentiation In Vitro and Enhances Chondrogenesis In Vivo.” In Vitro Cellular & Developmental Biology. Animal 52 (3): 356–364. doi:https://doi.org/10.1007/s11626-015-9969-9.
   PubMedGoogle Scholar